UniProt | Protein Name |
---|---|
P98160 |
|
GO Term | Evidence Code | PMID |
---|---|---|
cell differentiation |
|
GO Term | Evidence Code | PMID |
---|---|---|
extracellular region | ||
Golgi lumen |
|
|
basement membrane |
|
|
plasma membrane |
|
|
focal adhesion |
GO Term | Evidence Code | PMID |
---|---|---|
low-density lipoprotein particle receptor binding |
|
|
amyloid-beta binding | ||
extracellular matrix structural constituent conferring compression resistance | ||
calcium ion binding | ||
protein binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:4001 | ovarian carcinoma | |
DOID:4015 | sarcomatoid carcinoma | |
DOID:417 | autoimmune disease | |
DOID:418 | systemic scleroderma | |
DOID:419 | scleroderma | |
DOID:4195 | hyperglycemia | |
DOID:4254 | osteosclerosis | |
DOID:4411 | hepatitis E | |
DOID:4448 | macular degeneration | |
DOID:4480 | achondroplasia |
HPO ID | HPO Term |
---|---|
HP:0003577 | Congenital onset |
HP:0003593 | Infantile onset |
HP:0003712 | Skeletal muscle hypertrophy |
HP:0003731 | Quadriceps muscle weakness |
HP:0003811 | Neonatal death |
HP:0004209 | Clinodactyly of the 5th finger |
HP:0004322 | Short stature |
HP:0004325 | Decreased body weight |
HP:0004326 | Cachexia |
HP:0004374 | Hemiplegia/hemiparesis |
Disease ID | Disease Name |
---|---|
ORPHA:1606 |
|
ORPHA:800 |
|
ORPHA:1865 |
|
OMIM:255800 |
|
OMIM:224410 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
175126 | WB:WBGene00006787 | ||
45320 | FB:FBgn0284408 | ||
565429 | ZFIN:ZDB-GENE-080807-4 | DANRE24960 | |
100380784 | SALSA43220 | ||
115165633 | SALTR88020 | ||
103467813 | POERE30093 | ||
102290874 | HAPBU05628 | ||
113013483 | ASTCA20652 | ||
108696836 | Xenbase:XB-GENE-17341349 | ||
100494785 | Xenbase:XB-GENE-6465357 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024